Page last updated: 2024-08-22

tungsten and ammonium tungsten antimonate hydroxide oxide

tungsten has been researched along with ammonium tungsten antimonate hydroxide oxide in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	34 (91.89)	18.7374
1990's	3 (8.11)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chermann, JC; Jasmin, C; Sinoussi, FC	1
Chermann, JC; Jasmin, C; Werner, GH	1
Atanasiu, P; Chermann, JC; Jasmin, C; Tsiang, H	1
Inouye, Y; Kunihara, J; Nakamura, S; Nakata, A; Tokutake, Y; Yamase, T; Yoshida, T	1
Hill, CL; Schinazi, RF; Weeks, MS	1
Berry, JP; Galle, P	1
Hirsch, MS; Kaplan, JC	1
Kimberlin, RH; Walker, CA	2
Buimovici-Klein, E; Cooper, LZ; Englard, A; Grieco, MH; Lange, M; McKinley, GF; Ong, KR; Reddy, M	1
Katinka, MD	1
Eliaszewicz, M; Frottier, J; Laporte, JP; Meyohas, MC; Najman, A; Woehrle, R	1
Barre-Sinoussi, F; Chermann, JC; Vittecoq, D; Woerle, R	1
Barré-Sinoussi, F; Chermann, JC; Nakane, H; Ono, K	1
Barre-Sinoussi, FC; Chermann, JC; Daveloose, D; Dormont, D; Lambert, P; Spire, B; Yeramian, P	1
Matthes, E; Reimer, K; Rosenthal, HA; Scholz, D	1
Burgard, M; Descamps, P; Guetard, D; Herson, S; Rouzioux, C; Rozenbaum, W; Sansonetti, P; Vittecoq, D	1
Aymard, JP; Ferry, R; Janot, C; Legras, B; May, T; Schooneman, F; Streiff, F	1
Kaplan, JC; Sandström, EG	1
Chottard, G; Hervé, G; Hervé, M; Michelon, M	1
Broder, S; Yarchoan, R	1
Barre-Sinoussi, F; Chermann, JC; Dormont, D; Gentilini, M; Griscelli, C; Montagnier, L; Rozenbaum, W; Spire, B; Vilmer, E	1
Blancou, J; Bussereau, F; Picard, M; Sureau, P	1
Sandström, E	1
Weber, J	1
Fauci, AS; Lane, HC	1
Marwick, C; Riesenberg, DE	1
Moskovitz, BL	1
Rada, B	1
Castagna, A; Crocchiolo, P; Lazzarin, A; Moroni, M; Orlando, G; Verani, P	1
Blancou, J; Pepin, M	1
Boy-Loustau, C; Chermann, JC; Herve, G; Jasmin, C; Raybaud, N; Raynaud, M; Sinoussi, F; Souchay, P; Teze, A	1
Barré-Sinoussi, F; Chermann, JC; Matsumoto, T; Nakane, H; Ono, K	1
Chermann, JC; Herve, G; Herve, M; Jasmin, C; Sinoussi-Barre, F	1
Chermann, JC; Jasmin, C; Ono, K; Souyri-Caporale, M; Tovey, MG	1
Cibert, C; Jasmin, C	1
Augery, Y; Chermann, JC; Degiorgis, V; Jasmin, C; Larnicol, N; Le Bousse-Kerdiles, C; Teze, A	1

Reviews

6 review(s) available for tungsten and ammonium tungsten antimonate hydroxide oxide

Article	Year
Prospects of therapy for infections with human T-lymphotropic virus type III. Annals of internal medicine, 1985, Volume: 103, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antimony; Antiviral Agents; Combined Modality Therapy; Deltaretrovirus; Foscarnet; Humans; Immunotherapy; Interferons; Lactams, Macrocyclic; Phosphonoacetic Acid; Receptors, Virus; Reverse Transcriptase Inhibitors; Ribavirin; RNA Processing, Post-Transcriptional; RNA, Viral; Suramin; Tungsten; Tungsten Compounds; Virus Replication	1985
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. Drugs, 1987, Volume: 34, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherapy; Phosphonoacetic Acid; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1987
Progress in the development of antiviral therapy for HTLV-III-associated diseases. Important advances in oncology, 1987 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1987
Antiviral drugs for AIDS. Current status and future prospects. Drugs, 1986, Volume: 31, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1986
Immunologic reconstitution in the acquired immunodeficiency syndrome. Annals of internal medicine, 1985, Volume: 103, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Antimony; Antiviral Agents; Bone Marrow Transplantation; Deltaretrovirus; Humans; Immunotherapy; Interferon Type I; Interferon-gamma; Interleukin-2; Lymphocyte Transfusion; Ribavirin; Suramin; Thymus Gland; Tungsten; Tungsten Compounds	1985
[Experimental chemotherapy of AIDS]. Casopis lekaru ceskych, 1988, May-27, Volume: 127, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptides; Peptide T; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1988

Trials

2 trial(s) available for tungsten and ammonium tungsten antimonate hydroxide oxide

Article	Year
Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS. AIDS (London, England), 1989, Volume: 3, Issue:10 Topics: Antimony; Antiviral Agents; Drug Evaluation; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Platelet Count; Random Allocation; Reverse Transcriptase Inhibitors; Thrombocytopenia; Tungsten; Tungsten Compounds; Viral Core Proteins	1989
Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Antiviral Agents; Aspartate Aminotransferases; Blood Cell Count; Clinical Trials as Topic; Drug Tolerance; Humans; Male; Platelet Count; T-Lymphocytes; Tungsten; Tungsten Compounds	1988

Article

Year

Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.

AIDS (London, England), 1989, Volume: 3, Issue:10

Topics: Antimony; Antiviral Agents; Drug Evaluation; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Platelet Count; Random Allocation; Reverse Transcriptase Inhibitors; Thrombocytopenia; Tungsten; Tungsten Compounds; Viral Core Proteins

1989

Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome.

Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:9

Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Antiviral Agents; Aspartate Aminotransferases; Blood Cell Count; Clinical Trials as Topic; Drug Tolerance; Humans; Male; Platelet Count; T-Lymphocytes; Tungsten; Tungsten Compounds

1988

Other Studies

29 other study(ies) available for tungsten and ammonium tungsten antimonate hydroxide oxide

Article	Year
Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate. Biochemical and biophysical research communications, 1975, Aug-18, Volume: 65, Issue:4 Topics: Antimony; DNA-Directed RNA Polymerases; Kinetics; Moloney murine leukemia virus; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Templates, Genetic; Tungsten; Tungsten Compounds	1975
Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice. The Journal of general virology, 1976, Volume: 31, Issue:1 Topics: Animals; Antimony; Antiviral Agents; Blood; Brain; Drug Synergism; Encephalomyocarditis virus; Enterovirus Infections; Female; Injections, Intraperitoneal; Interferons; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Tungsten; Tungsten Compounds; Vesicular stomatitis Indiana virus; Virus Diseases; Virus Replication	1976
Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate. The Journal of general virology, 1978, Volume: 40, Issue:3 Topics: Antimony; Antiviral Agents; Dose-Response Relationship, Drug; Rabies virus; Tungsten; Tungsten Compounds; Viral Plaque Assay	1978
Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase. Chemical & pharmaceutical bulletin, 1992, Volume: 40, Issue:3 Topics: Antimony; Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; HIV-1; Humans; Polymers; Reverse Transcriptase Inhibitors; Tungsten; Tungsten Compounds	1992
Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates. Journal of medicinal chemistry, 1990, Volume: 33, Issue:10 Topics: Antimony; Antiviral Agents; Cell Survival; Cells, Cultured; Chemical Phenomena; Chemistry, Physical; HIV; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Magnetic Resonance Spectroscopy; Structure-Activity Relationship; Tungsten; Tungsten Compounds	1990
Subcellular localization of HPA-23 in different rat organs: electron microprobe study. Experimental and molecular pathology, 1990, Volume: 53, Issue:3 Topics: Animals; Antimony; Antiviral Agents; Dose-Response Relationship, Drug; Electron Probe Microanalysis; Rats; Tissue Distribution; Tungsten; Tungsten Compounds	1990
Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:3 Topics: Animals; Antimony; Carrageenan; Dextran Sulfate; Dextrans; Female; Mice; Molecular Weight; Scrapie; Tungsten; Tungsten Compounds	1986
Reverse transcriptase activity (RTA) in lymphocyte cultures of AIDS patients treated with HPA-23. AIDS research, 1986,Fall, Volume: 2, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Antiviral Agents; Drug Evaluation; Humans; Lymphocytes; Male; Middle Aged; RNA-Directed DNA Polymerase; Tungsten; Tungsten Compounds	1986
RNA-dependent DNA polymerase activity in Paramecium tetraurelia: what for? European journal of biochemistry, 1987, Mar-16, Volume: 163, Issue:3 Topics: Animals; Antimony; Avian Myeloblastosis Virus; Cell Cycle; Centrifugation, Density Gradient; Dose-Response Relationship, Drug; Ethidium; Foscarnet; Magnesium; Manganese; Paramecium; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Suramin; Templates, Genetic; Tungsten; Tungsten Compounds	1987
[Addition of HPA 23 to cyclosporin in the treatment of thrombopenic purpura in HIV-positive subjects]. Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2 Topics: Adult; Antimony; Cyclosporins; Drug Therapy, Combination; HIV Seropositivity; Humans; Male; Purpura, Thrombocytopenic; Reverse Transcriptase Inhibitors; Tungsten; Tungsten Compounds	1987
Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1988, Volume: 42, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Cells, Cultured; Half-Life; Humans; Lymphocytes; RNA-Directed DNA Polymerase; Thrombocytopenia; Time Factors; Tungsten; Tungsten Compounds	1988
Differential inhibition of various mammalian DNA polymerase activities by ammonium 21-tungsto-9-antimoniate (HPA23). European journal of biochemistry, 1988, Sep-15, Volume: 176, Issue:2 Topics: Animals; Antimony; Antiviral Agents; Cell Line; DNA Polymerase I; DNA Polymerase II; DNA Polymerase III; HIV; Humans; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Tungsten; Tungsten Compounds	1988
Cellular and molecular mechanisms of antiretroviral effects of HPA23. Cancer detection and prevention, 1988, Volume: 12, Issue:1-6 Topics: Antimony; Antiviral Agents; Cell Fractionation; Electron Spin Resonance Spectroscopy; HIV; Humans; Kinetics; Lymphocytes; Microscopy, Electron; Reverse Transcriptase Inhibitors; Spectrophotometry; Tungsten; Tungsten Compounds; Virus Replication	1988
Effects of suramin, HPA-23 and 3'-azidothymidine triphosphate on the reverse transcriptase of bovine leukaemia virus. Acta virologica, 1989, Volume: 33, Issue:1 Topics: Animals; Antimony; Antiviral Agents; Cattle; Kinetics; Leukemia Virus, Bovine; Models, Biological; Retroviridae; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Suramin; Tungsten; Tungsten Compounds; Zidovudine	1989
Toxicity of HPA-23 (ammonium-21-tungsto-9-antimoniate) for normal human myeloid progenitor cells (GM-CFU) in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1989, Volume: 43, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Antimony; Antiviral Agents; Child; Dose-Response Relationship, Drug; Female; Granulocytes; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Tungsten; Tungsten Compounds	1989
Modification of the structural and redox properties of cytochrome c by heteropolytungstate binding. Biochimica et biophysica acta, 1987, Dec-18, Volume: 916, Issue:3 Topics: Animals; Antimony; Arsenic; Cytochrome c Group; Electron Spin Resonance Spectroscopy; Horses; Hydrogen-Ion Concentration; Oxidation-Reduction; Potentiometry; Silicon; Tungsten; Tungsten Compounds	1987
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (London, England), 1985, Feb-23, Volume: 1, Issue:8426 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antimony; Deltaretrovirus; Female; Humans; Male; Tungsten; Tungsten Compounds	1985
Treatment of rabies in mice and foxes with antiviral compounds. Acta virologica, 1988, Volume: 32, Issue:1 Topics: Animals; Antimony; Antiviral Agents; Drug Evaluation, Preclinical; Foxes; Injections, Intramuscular; Injections, Intraventricular; Male; Mice; Rabies; Time Factors; Tungsten; Tungsten Compounds	1988
AIDS: the virus, antivirals and vaccines. British journal of hospital medicine, 1987, Volume: 37, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans; Phosphonoacetic Acid; Suramin; Thymidine; Tungsten; Tungsten Compounds; Viral Vaccines; Virus Replication; Zidovudine	1987
Anti-AIDS agents show varying early results in vitro and in vivo. JAMA, 1985, Nov-08, Volume: 254, Issue:18 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1985
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antimony; Antiviral Agents; Humans; Interferon Type I; Ribavirin; Ribonucleosides; Tungsten; Tungsten Compounds	1987
Ammonium-5-tungsto-2-antimoniate (HPA23) can prevent fox rabies. Archives of virology, 1985, Volume: 83, Issue:3-4 Topics: Animals; Antimony; Antiviral Agents; Foxes; Lethal Dose 50; Rabies; Tungsten; Tungsten Compounds	1985
In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate. Journal of the National Cancer Institute, 1974, Volume: 53, Issue:2 Topics: Animals; Antigens, Viral; Antimony; Antiviral Agents; Friend murine leukemia virus; Gammaretrovirus; Immunization; Interferon Inducers; Leukemia L1210; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Moloney murine leukemia virus; Sarcoma; Sarcoma, Experimental; Splenomegaly; Tungsten; Tungsten Compounds	1974
Inhibition of DNA polymerase alpha activity by ammonium 21-tungsto-9-antimoniate (HPA23). Nucleic acids symposium series, 1984, Issue:15 Topics: Animals; Antimony; Antiviral Agents; Burkitt Lymphoma; Cell Line; DNA Polymerase I; DNA Polymerase II; Herpesvirus 4, Human; Humans; Kinetics; Mice; Plasmacytoma; Tungsten; Tungsten Compounds	1984
Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases. Biochemical and biophysical research communications, 1983, Oct-14, Volume: 116, Issue:1 Topics: Antimony; Arsenates; DNA-Directed RNA Polymerases; Escherichia coli; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Substrate Specificity; Tungsten; Tungsten Compounds	1983
Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine. The Journal of general virology, 1984, Volume: 65 ( Pt 4) Topics: Antigens, Viral; Antimony; Cell Line; DNA; DNA Polymerase II; DNA-Directed DNA Polymerase; Herpesvirus 4, Human; Humans; Idoxuridine; Interphase; Time Factors; Tungsten; Tungsten Compounds; Virus Activation	1984
The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Archives of virology, 1983, Volume: 78, Issue:1-2 Topics: Animals; Antimony; Antiviral Agents; Cricetinae; Female; Mesocricetus; Mice; Scrapie; Sheep; Tungsten; Tungsten Compounds	1983
Determination of the intracellular localization of a polyoxotungstate (HPA-23) by Raman Laser and X fluorescence spectroscopies. Biochemical and biophysical research communications, 1982, Oct-29, Volume: 108, Issue:4 Topics: Animals; Antimony; Cells, Cultured; Electron Probe Microanalysis; Fibroblasts; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Spectrum Analysis, Raman; Tungsten; Tungsten Compounds	1982
In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia. The Journal of general virology, 1981, Volume: 55, Issue:Pt 1 Topics: Animals; Antimony; Antiviral Agents; Erythropoiesis; Friend murine leukemia virus; Leukemia, Experimental; Mice; Splenomegaly; Time Factors; Tungsten; Tungsten Compounds	1981